Search for content, post, videos

Category

Biotech

lars-hedbys
0 COMMENT
34 Views
Idogen’s technology granted European patent

Idogen announces that the European Patent Office will formally grant a patent application, covering the company’s tolerogenic vaccine technology. The EPO approval strengthens the company’s patent portfolio for the vaccine technology. A patent in the same patent family has already been granted in Japan and a Notice of Allowance has…

sara-gunnerås
0 COMMENT
7 Views
Swedish drug development on the rise

Earlier today, SwedenBIO presented its annual report on the Swedish drug discovery and development pipeline, showing for example that the number of clinical stage drug development projects has increased from 63 to 144 in 5 years. The report provides facts and figures about the current Swedish drug development pipeline for…

Oresund Bridge
0 COMMENT
2 Views
BIO-Europe to be held in Medicon Valley

Europe’s largest biotech conference BIO-Europe will be held in Copenhagen and Malmö in 2018. A contributing factor to the decision was the strong Swedish-Danish cooperation between the private and public sectors. According to Novo Nordisk, one of the companies that has been involved in landing the conference, BIO-Europe will pave…

copenhagen
0 COMMENT
1 Views
Denmark’s biotech sector best in Europe  

For the second year running, Denmark’s biotech sector is awarded a global top three ranking by Scientific American Worldview and is praised for its generous public sector investment and speedy drug trial application process. Denmark takes the global top three spot in the 2016 Scientific American Worldview Scorecard, assessing countries…

pci_biotech
0 COMMENT
3 Views
PCI Biotech receives positive opinion from EMA

PCI Biotech has announced that it has received a positive opinion from the European Medicine Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) for its lead product candidate, fimaporfin, for the treatment of cholangiocarcinoma (bile duct cancer). COMP’s positive opinion is subject to decision by the European Commission for Orphan…

0 COMMENT
6 Views
NOK 250 million to biotech

The Research Council of Norway has awarded NOK 250 million in funding under the new biotechnology initiative on digital life for the establishment of a national centre. Six large-scale Researcher Projects will be carried out under the auspices of the centre, with topics spanning from aquaculture to brain research. Under…

0 COMMENT
1 Views
Biotech Firm Wins Pitch Contest

MyOroface, a biotech Umeå and Uminova Innovation supported company, won 100,000 SEK at the ALMI Invests pitch competition. Twenty business ideas were selected to give their company pitch in front of an experienced investors’ panel, which included representatives from SEB Venture Capital, Dohi and ALMI invest, according to Biotech Umeå.…

Research-and-development-AZ
0 COMMENT
3 Views
Norway Joins Biotech Assoc.

The Norwegian Bioindustry Association is one of 20 founding members of the International Council of Biotechnology Associations (ICBA). The goal of the ICBA is to advocate for public policies that support the growth of the biotechnology industry worldwide. Jim Greenwood, president and chief executive officer of the Biotechnology Industry Organization…

0 COMMENT
2 Views
Denmark’s biotech pipeline on top

Danish biotech and drug companies are among the best in Europe when it comes to the number of candidate drugs under development, according to a new study. Nordic Life Sciences sector study 2014, by Ernst & Young, concludes that Denmark has the largest pipeline of drugs undergoing clinical trials in Europe…

0 COMMENT
0 Views
Danish biotech company among top SMEs

The European Association for Bioindustries has announced the top five biotech SMEs in Europe and Danish Biosyntia is among the five contenders. Biosyntia and the other four companies will compete to win the award as the ‘Most Innovative EU Biotech SME’. The other contenders are UK-based healthcare biotech company, Autifony; the Italian industrial…

0 COMMENT
1 Views
BerGenBio granted platform patent

The Norwegian oncology biopharmaceutical company has announced that the United States Patent and Trademark Office (USPTO) has issued United States Patent 8,735,064 covering a method for creating and identifying functional interference RNA (RNAi) molecules. RNAis are recombinant nucleic acid molecules that have the ability to specifically down-regulate an expressed target gene in vivo. This patent…

Novozymes
0 COMMENT
2 Views
Novozymes to open new R&D center in the US

Novozymes has announced the establishment of a new research and development center in the US dedicated to its bioagriculture business. The center will be located near the Research Triangle Park in Cary, North Carolina where the company will, according to Novozymes, invest $36 million over the next three years and…

0 COMMENT
2 Views
No preliminary investigation on Active Biotech

In the end of February Active Biotech was reported to the Swedish Economic Crime Authority, which has now decided not to precede with a preliminary investigation. The complaint to the Swedish Economic Crime Authority came from the organization INDEIN (Investigation Development for Investors). As reported in the web edition of the…

0 COMMENT
0 Views
Active Biotech reported for economic crime

The Lund-based pharmaceutical company has been reported to the Swedish Economic Crime Authority. Active Biotech is accused to have to misinformed their investors. Allegedly, the firm was aware of the that the MS drug Nerventra should have been stopped but concealed it. On January 25, the company share went down…